Regulatory Insights

  1. Paper COAs In 2026? It's Not "Cheaper," It's Riskier 4/1/2026

    Paper-based assessments add operational and regulatory risk — from poor data quality to delayed insights — quietly threatening timelines, compliance, and trial confidence.

  2. Which FIH Decisions Are Hardest To Reverse Later? 3/31/2026

    Early oncology trial decisions can lock in risk, shape regulatory confidence, and limit flexibility. Knowing which choices are hardest to reverse protects optionality and credibility.

  3. Medical Device Clinical Trials: Key Considerations For Sponsors And CROs 3/30/2026

    Medical device trials must align risk class, regulations, and study design. Strong oversight, data, and proactive safety planning support reliable evidence and market approval.

  4. A Guide To Medical Coding In Clinical Trials 3/30/2026

    Medical coding transforms free-text clinical data into standardized terminology, enabling consistent analysis, safety monitoring, and regulatory review. Clear guidelines and quality control help reduce variability and protect data integrity across the entire clinical trial lifecycle.

  5. Staying Audit-Ready: Practical Compliance Insights For Clinical Research Sites 3/26/2026

    Gain an auditor’s insight into common compliance gaps and learn practical ways to strengthen audit readiness in sIRB studies. 

  6. The Patient Experience Paradox: eCOA Strategy Overhaul 3/25/2026

    European regulatory shifts now require the systematic integration of patient data. Success depends on aligning clinical and market access strategies through rigorous evidence generation.

  7. Implications Of Assessing Overall Survival In Oncology Studies 3/25/2026

    New oncology standards mandate pre-specified survival analysis to catch long-term harm. Learn how to implement hazard ratio thresholds and the ICH E9(R1) framework for global compliance.

  8. The End Of The "PRO Tax": Top 10 Commercial PROs & Their Cost-Effective Alternatives 3/25/2026

    Regulators now prioritize fit-for-purpose data over legacy instrument brand names. Modernizing your assessment strategy reduces licensing delays and improves trial startup speed and efficiency.

  9. 10 Clinical Research Practices That Feel Like Compliance (But Aren't) 3/24/2026

    Many clinical research routines are driven by habit, not regulation. This guide clears up 10 common misconceptions to streamline workflows and reduce unnecessary admin work.

  10. European Clinical Supply Planning – Balancing Cost, Flexibility And Time 3/24/2026

    See how study characteristics, regulatory landscapes, and business priorities combine to inform clinical supply placement decisions between EU and non-EU European locations.